Newport Pharmaceuticals: Newport Pharmaceuticals International, which lost...
Newport Pharmaceuticals: Newport Pharmaceuticals International, which lost $2.6 million in its fiscal 1990 year, started the new fiscal year by earning $294,000 on revenue of $20.4 million for the first quarter ended March 31, the company said. In the first quarter last year, the Laguna Hills company lost $401,000 on revenue of $13.3 million. Newport Pharmaceuticals’ principal business is providing prescription drug-benefit programs to corporate health-care providers, insurers and health maintenance organizations.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.